Tag: Nursing

  • [Solved] concept map

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering concept map.

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] PHILOSOPHY DISCUSSION 6

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – 2 years ago **files (1)** – ## MODULE6PHILOSOPHYDISCUSSION.docx **## MODULE6PHILOSOPHYDISCUSSION.docx** **Module 6 Discussion** ![icon](https://www.sweetstudy.com/questions/philosophy-discussion-6-20901573)**_Personhood_** Discuss the concept of personhood as used in the nursing as caring theory. …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – 2 years ago

    **files (1)**

    – ## MODULE6PHILOSOPHYDISCUSSION.docx

    **## MODULE6PHILOSOPHYDISCUSSION.docx**

    **Module 6 Discussion**

    ![icon](https://www.sweetstudy.com/questions/philosophy-discussion-6-20901573)**_Personhood_**

    Discuss the concept of personhood as used in the nursing as caring theory.

    **Submission Instructions:**

    · Your initial post must be at least 500 words, formatted, and cited in current APA style with support from at least two academic sources.

    · Quotes “……” cannot be used at a higher learning level for your assignments, so sentences need to be paraphrased and referenced.

    · Acceptable references include scholarly journal articles or primary legal sources (statutes, court opinions), journal articles, and books published in the last five years-no websites to be referenced without prior approval.

    ## image1.png

    **## MODULE6PHILOSOPHYDISCUSSION.docx**

    **Module 6 Discussion**

    ![icon](https://www.sweetstudy.com/questions/philosophy-discussion-6-20901573)**_Personhood_**

    Discuss the concept of personhood as used in the nursing as caring theory.

    **Submission Instructions:**

    · Your initial post must be at least 500 words, formatted, and cited in current APA style with support from at least two academic sources.

    · Quotes “……” cannot be used at a higher learning level for your assignments, so sentences need to be paraphrased and referenced.

    · Acceptable references include scholarly journal articles or primary legal sources (statutes, court opinions), journal articles, and books published in the last five years-no websites to be referenced without prior approval.

    ## image1.png

  • [Solved] PHARM DISCUSSION 6

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – 2 years ago **files (1)** – ## MODULE6PHARMDISCUSSION.docx **## MODULE6PHARMDISCUSSION.docx** **Module 6 Discussion** ![icon](https://www.sweetstudy.com/questions/pharm-discussion-6-20901571)**Treatments for** **Genitourinary Tract Disorders** Based on [Module 6: Lecture Materials & Resources](htt…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – 2 years ago

    **files (1)**

    – ## MODULE6PHARMDISCUSSION.docx

    **## MODULE6PHARMDISCUSSION.docx**

    **Module 6 Discussion**

    ![icon](https://www.sweetstudy.com/questions/pharm-discussion-6-20901571)**Treatments for**
    **Genitourinary Tract Disorders**

    Based on
    [Module 6: Lecture Materials & Resources](https://stu.instructure.com/courses/44860/pages/module-6-lecture-materials-and-resources?wrap=1) and experience, please answer the following questions:

    1. Describe urinary tract infection, causes, symptoms and treatment

    2. Discuss treatment for benign prostatic hyperplasia

    3. Describe overactive bladder, causes, symptoms and treatment

    4. Treatment options and recommendations for different STIs (Chlamydia, Gonorrhea and Syphilis)

    **Submission Instructions:**

    · Your initial post must be at least 500 words, formatted, and cited in current APA style with support from at least two academic sources.

    Each question must be answered individually as in bullet points. Not in an essay format. Example: Question 1, followed by the answer to question 1; Question 2, followed by the answer to question 2; and so forth.

    · Each question
    **must be answered individually** as in bullet points.
    **Not** in an essay format.

    · Quotes “……” cannot be used at a higher learning level for your assignments, so sentences need to be paraphrased and referenced.

    · Acceptable references include scholarly journal articles or primary legal sources (statutes, court opinions), journal articles, and books published in the last five years-no websites to be referenced without prior approval.

    ## image1.png

    **## MODULE6PHARMDISCUSSION.docx**

    **Module 6 Discussion**

    ![icon](https://www.sweetstudy.com/questions/pharm-discussion-6-20901571)**Treatments for**
    **Genitourinary Tract Disorders**

    Based on
    [Module 6: Lecture Materials & Resources](https://stu.instructure.com/courses/44860/pages/module-6-lecture-materials-and-resources?wrap=1) and experience, please answer the following questions:

    1. Describe urinary tract infection, causes, symptoms and treatment

    2. Discuss treatment for benign prostatic hyperplasia

    3. Describe overactive bladder, causes, symptoms and treatment

    4. Treatment options and recommendations for different STIs (Chlamydia, Gonorrhea and Syphilis)

    **Submission Instructions:**

    · Your initial post must be at least 500 words, formatted, and cited in current APA style with support from at least two academic sources.

    Each question must be answered individually as in bullet points. Not in an essay format. Example: Question 1, followed by the answer to question 1; Question 2, followed by the answer to question 2; and so forth.

    · Each question
    **must be answered individually** as in bullet points.
    **Not** in an essay format.

    · Quotes “……” cannot be used at a higher learning level for your assignments, so sentences need to be paraphrased and referenced.

    · Acceptable references include scholarly journal articles or primary legal sources (statutes, court opinions), journal articles, and books published in the last five years-no websites to be referenced without prior approval.

    ## image1.png

  • [Solved] why

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering why.

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] Nursing Homework

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – a year ago **files (1)** – PsychiatricSOAPNoteRubric.docx **PsychiatricSOAPNoteRubric.docx** This file is too large to display. [View in new window](https://www.sweetstudy.com/files/psychiatricsoapnoterubric-docx-10272187) **PsychiatricSOAPNoteRubric.docx** This file is too large to display. [View…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – a year ago

    **files (1)**

    – PsychiatricSOAPNoteRubric.docx

    **PsychiatricSOAPNoteRubric.docx**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/psychiatricsoapnoterubric-docx-10272187)

    **PsychiatricSOAPNoteRubric.docx**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/psychiatricsoapnoterubric-docx-10272187)

  • [Solved] writing

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering writing.

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] help with discussion

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    Hello! I need help with my discussion – [\ \ Screenshot2025-04-23at10.03.07AM.png](https://www.sweetstudy.com/files/screenshot2025-04-23at10-03-07am-png "Screenshot2025-04-23at10.03.07AM.png") – 2 years ago

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Hello! I need help with my discussion

    – [\
    \
    Screenshot2025-04-23at10.03.07AM.png](https://www.sweetstudy.com/files/screenshot2025-04-23at10-03-07am-png "Screenshot2025-04-23at10.03.07AM.png")

    – 2 years ago

  • [Solved] WK 9 Resp, Epid

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – 2 years ago **files (1)** – ## WK9DIS.EPIDEradicationofSmallpox.docx **## WK9DIS.EPIDEradicationofSmallpox.docx** Eradication of Smallpox, Polio, and how they may help in Approaching Covid-19 ![A syringe being needled into a vial AI-generated content may be incorrect.](https://www.sweetstudy.com/q…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – 2 years ago

    **files (1)**

    – ## WK9DIS.EPIDEradicationofSmallpox.docx

    **## WK9DIS.EPIDEradicationofSmallpox.docx**

    Eradication of Smallpox, Polio, and how they may help in Approaching Covid-19

    ![A syringe being needled into a vial AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/wk-9-resp-epid-20901627)

    Some of the most notable epidemics include the bubonic plague in the 14th century, smallpox in the 18th century, influenza in the 20th century, and SARS-CoV-2 (COVID-19) in the 21st century. It is estimated that the bubonic plague caused 25 million deaths in Europe in the 14th century alone, and up to 200 million total deaths across centuries (Glatter & Finkelman, 2021). The COVID-19 pandemic spread at an unprecedented pace due to globalization and the mobility of society, killing millions worldwide. These are dramatic examples of the kinds of acute outbreaks that make epidemiology such an important field of study.

    At the beginning of the 21st century, many epidemiologists and healthcare professionals were concerned about the next potential pandemic or epidemic—and then it arrived in early 2020. Globalization means that when these infectious outbreaks occur, they can spread quickly, but we also have more knowledge and better tools (e.g., vaccine technology) to fight them. For this Discussion, you will compare lessons learned from two successful eradication efforts, that of smallpox and polio, and consider how they may be applied to COVID-19.

    **Reference**

    Glatter, K. A., & Finkelman, P. (2021). History of the plague: An ancient pandemic for the age of COVID-19.
    _American Journal of Medicine, 134_(2), 176–181. https://doi.org/10.1016/j.amjmed.2020.08.019

    Resources

    Be sure to review the Learning Resources before completing this activity.
    Click the weekly resources link to access the resources.

    [**WEEKLY RESOURCES**](https://waldenu.instructure.com/courses/155998/modules/items/6259972)

    Learning Resources

    [Required Readings](https://waldenu.instructure.com/courses/155998/pages/week-9-learning-resources?module_item_id=6259972)

    · Friis, R. H., & Sellers, T. A. (2021).
    _Epidemiology for public health practice_ (6th ed.). Jones & Bartlett.

    · Chapter 12, “Epidemiology of Infectious Diseases

    · Center for Global Development. (n.d.).
    [_Case 1: Eradicating smallpox_](https://waldenu.instructure.com/courses/155998/files/12410777?wrap=1) [Download Case 1: Eradicating smallpox](https://waldenu.instructure.com/courses/155998/files/12410777/download?download_frd=1). http://www.cgdev.org/doc/millions/MS_case_1.pdf
    **Note:** This article provides an overview of the eradication of smallpox.

    · Wilson, N., Mansoor, O. D., Boyd, M. J., Kvalsvig, A., & Baker, M. G. (2021).
    [We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polioLinks to an external site.](https://doi.org/10.1136/bmjgh-2021-006810).
    _BMJ Global Health_, (8), e006810
    _._ https://doi.org/10.1136/bmjgh-2021-006810

    · World Health Organization. (n.d.).
    [PoliomyelitisLinks to an external site.](https://www.who.int/health-topics/poliomyelitis) _(polio)_. https://www.who.int/health-topics/poliomyelitis#tab=tab_1
    **Note:** This page provides an overview of the eradication of polio, as well as symptoms and treatment.

    [Required Media](https://waldenu.instructure.com/courses/155998/pages/week-9-learning-resources?module_item_id=6259972)

    · The Impact of COVID-19 on Epidemiology
    **Time Estimate:** 3 minutes

    · Walden University, LLC. (2021).
    [Infectious disease basicsLinks to an external site.](https://cdn-media.waldenu.edu/2dett4d/Walden/PHLT/8072/IDB/index.html) [Interactive media]. Walden University Blackboard. https://waldenu.instructure.com

    [Optional Resources](https://waldenu.instructure.com/courses/155998/pages/week-9-learning-resources?module_item_id=6259972)

    · Polio Global Eradication Initiative. (n.d.).
    [GPEI strategy 2022–2026.Links to an external site.](https://polioeradication.org/gpei-strategy-2022-2026/) https://polioeradication.org/gpei-strategy-2022-2026/

    To prepare:

    · Review the Learning Resources, focusing on the smallpox and polio epidemics and how health organizations applied principles of epidemiology to eradicate (or in the case of polio, nearly eradicate) these diseases.

    · In light of these examples, consider the benefits of addressing smallpox and polio at the population level. What were the population health strategies that were used in the efforts to eradicate smallpox and polio?

    · Consider similarities and differences from an epidemiologic perspective among the smallpox and polio epidemics and that of COVID-19.

    · Think about how principles of epidemiology are being applied—or could be applied—to address COVID-19.

    · What lessons from the use of infectious disease epidemiology in the past might be applicable to controlling COVID 19?

    · What are the benefits of addressing this issue at the population level as opposed to the individual level?

    By Day 3 of Week 9

    **Post** a cohesive response that addresses the following:

    · Briefly summarize the epidemiologic differences among the three diseases and how principles of epidemiology are being applied—or could be applied—to address COVID-19.

    · Are there any lessons learned from the use of epidemiology in the eradication of smallpox and polio that could be applied to COVID-19?

    · Evaluate the benefits of addressing this health problem at the population level versus the individual level. Support your Discussion with information from this week’s Learning Resources and articles you have located in the Walden Library.

    By Day 6 of Week 9

    **Read** a selection of your colleagues’ responses and respond to
    **at least two** of your colleagues on
    **two different days** and
    **respond** to
    **at least two** colleagues on
    **two different days** in one or more of the following ways:

    · Ask a probing question, substantiated with additional background information, evidence, or research.

    · Share an insight from having read your colleagues’ postings, synthesizing the information to provide new perspectives.

    · Offer and support an alternative perspective using readings from the classroom or from your own research in the Walden Library.

    · Validate an idea with your own experience and additional research.

    · Make a suggestion based on additional evidence drawn from readings or after synthesizing multiple postings.

    · Expand on your colleagues’ postings by providing additional insights or contrasting perspectives based on readings and evidence.

    RESPOND TO THIS DISCUSSION POST

    Yvonne

    **Lessons from Smallpox and Polio Eradication for Addressing COVID-19**

    The eradication campaigns for smallpox and the near-eradication of polio stand as two of the most significant achievements in public health history. These efforts offer valuable insights for managing and potentially controlling COVID-19. Though the three diseases differ in transmission, clinical presentation, and global response strategies, they share common epidemiologic principles that can inform future public health planning.

    Smallpox was officially eradicated in 1980 after a concerted global effort that emphasized widespread vaccination, intense surveillance, and containment strategies such as ring vaccination. One of the main reasons smallpox was deemed eradicable was its unique epidemiological profile: it had no animal reservoir, a clearly recognizable rash for easy diagnosis, and a relatively long incubation period, allowing health workers to isolate and vaccinate contacts before secondary transmission occurred (Center for Global Development, n.d.). A freeze-dried vaccine, the introduction of the bifurcated needle for easier delivery, and strong international cooperation made mass immunization feasible even in low-resource settings. Additionally, the global coordination led by the World Health Organization ensured unified strategies across nations, regardless of geopolitical differences.

    Polio, while not yet eradicated, has been dramatically reduced worldwide. Like smallpox, it has no known animal reservoir and only affects humans. However, eradication has been complicated by asymptomatic cases, persistent outbreaks in conflict zones, and rare instances of vaccine-derived poliovirus. Despite these challenges, strategies such as National Immunization Days, environmental surveillance (such as wastewater monitoring), and the oral polio vaccine have brought the world significantly closer to complete eradication (World Health Organization, n.d.).

    COVID-19 presents a different set of epidemiological challenges. Unlike smallpox and polio, SARS-CoV-2 spreads extensively through asymptomatic individuals and mutates rapidly, leading to new variants that may partially evade immune responses. These features make containment and eradication more difficult. However, the application of modern public health tools, such as genomic surveillance, contact tracing, and highly effective mRNA vaccines, gives us new options that were not available during the smallpox and early polio campaigns.

    Wilson et al. (2021) suggest that COVID-19's eradicability, although lower than that of smallpox, may be more feasible than polio in some respects. For example, successful elimination of COVID-19 has already been demonstrated in several jurisdictions, such as New Zealand and Iceland, through the use of public health and social measures like border control, mask-wearing, and testing. These countries achieved local elimination even before the availability of vaccines, demonstrating the power of coordinated interventions. Moreover, public health and social measures can complement vaccination efforts, making COVID-19 uniquely responsive to layered interventions compared to past diseases.

    One of the most significant lessons from smallpox and polio is the importance of political commitment, coordinated leadership, and robust surveillance systems. During the smallpox eradication campaign, the World Health Organization established a centralized Smallpox Eradication Unit that oversaw operations and enforced accountability. Similar infrastructure is needed for global COVID-19 management, especially in light of vaccine nationalism and inconsistent messaging. Misinformation and vaccine hesitancy are substantial barriers that must be addressed through consistent public health communication and community engagement.

    Addressing COVID-19 at the population level provides greater benefits than targeting individual treatment alone. A population-level approach enables mass vaccination campaigns, surveillance of disease spread through environmental monitoring, and resource allocation to underserved regions. Wastewater surveillance, for instance, has proven effective in detecting emerging outbreaks of COVID-19 and guiding targeted public health responses (Wilson et al., 2021). Such tools were similarly valuable in the polio campaign and continue to inform global efforts.

    The economic and health benefits of eradication are substantial. The smallpox campaign, for example, cost around $300 million globally but now saves billions in vaccination and treatment costs each year. COVID-19 has already imposed trillions of dollars in global economic losses, suggesting that investments in eradication or long-term control would be cost-effective in the long run.

    In conclusion, the eradication of smallpox and near-eradication of polio underscore the power of coordinated global efforts, scientific innovation, and flexible public health strategies. These lessons remain highly relevant in the ongoing battle against COVID-19. While full eradication of COVID-19 may be more complex, a strategic, population-based approach grounded in epidemiologic principles could lead to sustained control, reduced transmission, and a healthier global population.

    **References**

    Center for Global Development. (n.d.).
    _Case 1: Eradicating Smallpox_.
    [http://www.cgdev.org/doc/millions/MS_case_1.pdfLinks to an external site.](http://www.cgdev.org/doc/millions/MS_case_1.pdf)

    Friis, R. H., & Sellers, T. A. (2021).
    _Epidemiology for public health practice_ (6th ed.). Jones & Bartlett.

    Wilson, N., Mansoor, O. D., Boyd, M. J., Kvalsvig, A., & Baker, M. G. (2021). We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polio.
    _BMJ Global Health_, 6(8), e006810.
    [https://doi.org/10.1136/bmjgh-2021-006810Links to an external site.](https://doi.org/10.1136/bmjgh-2021-006810)

    World Health Organization. (n.d.).
    _Poliomyelitis (polio)_.
    [https://www.who.int/health-topics/poliomyelitis#tab=tab_1Links to an external site.](https://www.who.int/health-topics/poliomyelitis)

    ## image1.jpeg

    **## WK9DIS.EPIDEradicationofSmallpox.docx**

    Eradication of Smallpox, Polio, and how they may help in Approaching Covid-19

    ![A syringe being needled into a vial AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/wk-9-resp-epid-20901627)

    Some of the most notable epidemics include the bubonic plague in the 14th century, smallpox in the 18th century, influenza in the 20th century, and SARS-CoV-2 (COVID-19) in the 21st century. It is estimated that the bubonic plague caused 25 million deaths in Europe in the 14th century alone, and up to 200 million total deaths across centuries (Glatter & Finkelman, 2021). The COVID-19 pandemic spread at an unprecedented pace due to globalization and the mobility of society, killing millions worldwide. These are dramatic examples of the kinds of acute outbreaks that make epidemiology such an important field of study.

    At the beginning of the 21st century, many epidemiologists and healthcare professionals were concerned about the next potential pandemic or epidemic—and then it arrived in early 2020. Globalization means that when these infectious outbreaks occur, they can spread quickly, but we also have more knowledge and better tools (e.g., vaccine technology) to fight them. For this Discussion, you will compare lessons learned from two successful eradication efforts, that of smallpox and polio, and consider how they may be applied to COVID-19.

    **Reference**

    Glatter, K. A., & Finkelman, P. (2021). History of the plague: An ancient pandemic for the age of COVID-19.
    _American Journal of Medicine, 134_(2), 176–181. https://doi.org/10.1016/j.amjmed.2020.08.019

    Resources

    Be sure to review the Learning Resources before completing this activity.
    Click the weekly resources link to access the resources.

    [**WEEKLY RESOURCES**](https://waldenu.instructure.com/courses/155998/modules/items/6259972)

    Learning Resources

    [Required Readings](https://waldenu.instructure.com/courses/155998/pages/week-9-learning-resources?module_item_id=6259972)

    · Friis, R. H., & Sellers, T. A. (2021).
    _Epidemiology for public health practice_ (6th ed.). Jones & Bartlett.

    · Chapter 12, “Epidemiology of Infectious Diseases

    · Center for Global Development. (n.d.).
    [_Case 1: Eradicating smallpox_](https://waldenu.instructure.com/courses/155998/files/12410777?wrap=1) [Download Case 1: Eradicating smallpox](https://waldenu.instructure.com/courses/155998/files/12410777/download?download_frd=1). http://www.cgdev.org/doc/millions/MS_case_1.pdf
    **Note:** This article provides an overview of the eradication of smallpox.

    · Wilson, N., Mansoor, O. D., Boyd, M. J., Kvalsvig, A., & Baker, M. G. (2021).
    [We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polioLinks to an external site.](https://doi.org/10.1136/bmjgh-2021-006810).
    _BMJ Global Health_, (8), e006810
    _._ https://doi.org/10.1136/bmjgh-2021-006810

    · World Health Organization. (n.d.).
    [PoliomyelitisLinks to an external site.](https://www.who.int/health-topics/poliomyelitis) _(polio)_. https://www.who.int/health-topics/poliomyelitis#tab=tab_1
    **Note:** This page provides an overview of the eradication of polio, as well as symptoms and treatment.

    [Required Media](https://waldenu.instructure.com/courses/155998/pages/week-9-learning-resources?module_item_id=6259972)

    · The Impact of COVID-19 on Epidemiology
    **Time Estimate:** 3 minutes

    · Walden University, LLC. (2021).
    [Infectious disease basicsLinks to an external site.](https://cdn-media.waldenu.edu/2dett4d/Walden/PHLT/8072/IDB/index.html) [Interactive media]. Walden University Blackboard. https://waldenu.instructure.com

    [Optional Resources](https://waldenu.instructure.com/courses/155998/pages/week-9-learning-resources?module_item_id=6259972)

    · Polio Global Eradication Initiative. (n.d.).
    [GPEI strategy 2022–2026.Links to an external site.](https://polioeradication.org/gpei-strategy-2022-2026/) https://polioeradication.org/gpei-strategy-2022-2026/

    To prepare:

    · Review the Learning Resources, focusing on the smallpox and polio epidemics and how health organizations applied principles of epidemiology to eradicate (or in the case of polio, nearly eradicate) these diseases.

    · In light of these examples, consider the benefits of addressing smallpox and polio at the population level. What were the population health strategies that were used in the efforts to eradicate smallpox and polio?

    · Consider similarities and differences from an epidemiologic perspective among the smallpox and polio epidemics and that of COVID-19.

    · Think about how principles of epidemiology are being applied—or could be applied—to address COVID-19.

    · What lessons from the use of infectious disease epidemiology in the past might be applicable to controlling COVID 19?

    · What are the benefits of addressing this issue at the population level as opposed to the individual level?

    By Day 3 of Week 9

    **Post** a cohesive response that addresses the following:

    · Briefly summarize the epidemiologic differences among the three diseases and how principles of epidemiology are being applied—or could be applied—to address COVID-19.

    · Are there any lessons learned from the use of epidemiology in the eradication of smallpox and polio that could be applied to COVID-19?

    · Evaluate the benefits of addressing this health problem at the population level versus the individual level. Support your Discussion with information from this week’s Learning Resources and articles you have located in the Walden Library.

    By Day 6 of Week 9

    **Read** a selection of your colleagues’ responses and respond to
    **at least two** of your colleagues on
    **two different days** and
    **respond** to
    **at least two** colleagues on
    **two different days** in one or more of the following ways:

    · Ask a probing question, substantiated with additional background information, evidence, or research.

    · Share an insight from having read your colleagues’ postings, synthesizing the information to provide new perspectives.

    · Offer and support an alternative perspective using readings from the classroom or from your own research in the Walden Library.

    · Validate an idea with your own experience and additional research.

    · Make a suggestion based on additional evidence drawn from readings or after synthesizing multiple postings.

    · Expand on your colleagues’ postings by providing additional insights or contrasting perspectives based on readings and evidence.

    RESPOND TO THIS DISCUSSION POST

    Yvonne

    **Lessons from Smallpox and Polio Eradication for Addressing COVID-19**

    The eradication campaigns for smallpox and the near-eradication of polio stand as two of the most significant achievements in public health history. These efforts offer valuable insights for managing and potentially controlling COVID-19. Though the three diseases differ in transmission, clinical presentation, and global response strategies, they share common epidemiologic principles that can inform future public health planning.

    Smallpox was officially eradicated in 1980 after a concerted global effort that emphasized widespread vaccination, intense surveillance, and containment strategies such as ring vaccination. One of the main reasons smallpox was deemed eradicable was its unique epidemiological profile: it had no animal reservoir, a clearly recognizable rash for easy diagnosis, and a relatively long incubation period, allowing health workers to isolate and vaccinate contacts before secondary transmission occurred (Center for Global Development, n.d.). A freeze-dried vaccine, the introduction of the bifurcated needle for easier delivery, and strong international cooperation made mass immunization feasible even in low-resource settings. Additionally, the global coordination led by the World Health Organization ensured unified strategies across nations, regardless of geopolitical differences.

    Polio, while not yet eradicated, has been dramatically reduced worldwide. Like smallpox, it has no known animal reservoir and only affects humans. However, eradication has been complicated by asymptomatic cases, persistent outbreaks in conflict zones, and rare instances of vaccine-derived poliovirus. Despite these challenges, strategies such as National Immunization Days, environmental surveillance (such as wastewater monitoring), and the oral polio vaccine have brought the world significantly closer to complete eradication (World Health Organization, n.d.).

    COVID-19 presents a different set of epidemiological challenges. Unlike smallpox and polio, SARS-CoV-2 spreads extensively through asymptomatic individuals and mutates rapidly, leading to new variants that may partially evade immune responses. These features make containment and eradication more difficult. However, the application of modern public health tools, such as genomic surveillance, contact tracing, and highly effective mRNA vaccines, gives us new options that were not available during the smallpox and early polio campaigns.

    Wilson et al. (2021) suggest that COVID-19's eradicability, although lower than that of smallpox, may be more feasible than polio in some respects. For example, successful elimination of COVID-19 has already been demonstrated in several jurisdictions, such as New Zealand and Iceland, through the use of public health and social measures like border control, mask-wearing, and testing. These countries achieved local elimination even before the availability of vaccines, demonstrating the power of coordinated interventions. Moreover, public health and social measures can complement vaccination efforts, making COVID-19 uniquely responsive to layered interventions compared to past diseases.

    One of the most significant lessons from smallpox and polio is the importance of political commitment, coordinated leadership, and robust surveillance systems. During the smallpox eradication campaign, the World Health Organization established a centralized Smallpox Eradication Unit that oversaw operations and enforced accountability. Similar infrastructure is needed for global COVID-19 management, especially in light of vaccine nationalism and inconsistent messaging. Misinformation and vaccine hesitancy are substantial barriers that must be addressed through consistent public health communication and community engagement.

    Addressing COVID-19 at the population level provides greater benefits than targeting individual treatment alone. A population-level approach enables mass vaccination campaigns, surveillance of disease spread through environmental monitoring, and resource allocation to underserved regions. Wastewater surveillance, for instance, has proven effective in detecting emerging outbreaks of COVID-19 and guiding targeted public health responses (Wilson et al., 2021). Such tools were similarly valuable in the polio campaign and continue to inform global efforts.

    The economic and health benefits of eradication are substantial. The smallpox campaign, for example, cost around $300 million globally but now saves billions in vaccination and treatment costs each year. COVID-19 has already imposed trillions of dollars in global economic losses, suggesting that investments in eradication or long-term control would be cost-effective in the long run.

    In conclusion, the eradication of smallpox and near-eradication of polio underscore the power of coordinated global efforts, scientific innovation, and flexible public health strategies. These lessons remain highly relevant in the ongoing battle against COVID-19. While full eradication of COVID-19 may be more complex, a strategic, population-based approach grounded in epidemiologic principles could lead to sustained control, reduced transmission, and a healthier global population.

    **References**

    Center for Global Development. (n.d.).
    _Case 1: Eradicating Smallpox_.
    [http://www.cgdev.org/doc/millions/MS_case_1.pdfLinks to an external site.](http://www.cgdev.org/doc/millions/MS_case_1.pdf)

    Friis, R. H., & Sellers, T. A. (2021).
    _Epidemiology for public health practice_ (6th ed.). Jones & Bartlett.

    Wilson, N., Mansoor, O. D., Boyd, M. J., Kvalsvig, A., & Baker, M. G. (2021). We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polio.
    _BMJ Global Health_, 6(8), e006810.
    [https://doi.org/10.1136/bmjgh-2021-006810Links to an external site.](https://doi.org/10.1136/bmjgh-2021-006810)

    World Health Organization. (n.d.).
    _Poliomyelitis (polio)_.
    [https://www.who.int/health-topics/poliomyelitis#tab=tab_1Links to an external site.](https://www.who.int/health-topics/poliomyelitis)

    ## image1.jpeg

  • [Solved] Responses

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In response to your peers, offer feedback on their implementation and ways to improve their program proposals. – [\ \ Responses.docx](https://www.sweetstudy.com/files/responses-docx-10271815 "Responses.docx") – 2 years ago

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    In response to your peers, offer feedback on their implementation and ways to improve their program proposals.

    – [\
    \
    Responses.docx](https://www.sweetstudy.com/files/responses-docx-10271815 "Responses.docx")

    – 2 years ago

  • [Solved] Lorem

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    case study – a year ago **files (1)** – ## Gowalk94.docx **## Gowalk94.docx** STI Due: Saturday, 4/26 **Patient** B.G. is a 22-year-old Caucasian female presenting with a 1-week history of painful genital sores. She reports a burning sensation with urination and notes the presence of multiple small …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    case study

    – a year ago

    **files (1)**

    – ## Gowalk94.docx

    **## Gowalk94.docx**

    STI

    Due: Saturday, 4/26

    **Patient**

    B.G. is a 22-year-old Caucasian female presenting with a 1-week history of painful genital sores. She reports a burning sensation with urination and notes the presence of multiple small blisters on her vulva that ruptured into ulcers. She denies any prior episodes of similar symptoms. She also reports low-grade fever and general malaise. Associated symptoms: Dysuria, Itching, Tingling sensation before the appearance of sores, No vaginal discharge.

    **instructions**

    · Please complete STI SOAP Note precisely like the SOAP note you completed earlier for me in Asthma.

    · Must have a primary diagnosis and three differential diagnoses

    · Every idea is cited and referenced with literature within 5 years

    · Must have the Medication the patient is taking, Allergies. Social history, Sexual history, family history

    · Must have a review of systems

    · Physical examination

    · Diagnostic studies

    · Treatment

    · Patient education

    · Follow up

    · Must be in a basic Microsoft Word document

    · APA format.

    References reachable and within 5 years

    **Sample Note – Please follow this exact to complete**

    ID: D. K is a 70-year-old African American female, born on 06/10/1969, who presents to the clinic for a follow-up and laboratory review. The patient is accompanied by her husband, and she is a reliable source of information.

    **Subjective:**

    **CC:** “I feel tired all the time, and I have had increased thirst and urination in the past three months.”

    **HPI:**

    D.K. is a 70-year-old African American female who presents for follow-up for lab review and management of symptoms of polydipsia, polyuria, and fatigue and a possible diagnosis of type 2 diabetes mellitus. The patient reported experiencing increased thirst, increased hunger, urinary frequency, and fatigue in the past three months. D. K thought it was due to her consumption of cucumber, which she had just started consuming, but decided to seek help when she observed occasional blurred vision. She has also noted a 6-pound weight loss in these in these months. The patient’s fasting blood glucose level last visit was 150mg/dl, and HbA1c was 7.5%, which led to a diagnosis of type 2 diabetes mellitus. D.K. has a family history of diabetes, and she is currently not on any diabetes medication. She is following up for lab review and management. The last dental examination was on February 23rd, 2024. The last eye exam was on August 1st, 2023.

    **Past Medical History:** Denies any past medical history.

    **Hospitalization / Surgical**:

    Denies past or current
    surgeries/hospitalizations since the last visit

    **Allergies:**

    Denies drug allergies.

    Denies food allergies

    Denies seasonal allergies

    **Medications:**

    1. Melatonin for Insomnia for sleep

    2. Ibuprofen 200mg, 8 hours by mouth as needed for aches and pain

    3. Centrum Multivitamin 1 tablet by mouth daily

    4. Denies any prescription medication

    **Vaccinations:**

    · All childhood vaccines are current

    · Last flu shot 09/15/ 2024.

    · Covid Vaccines 01/14/2023, Covid Booster 03/15/2023

    **LMP:** The patient is post-menopausal

    **Family History:**

    The patient’s mother is 74 years old – with a history of type 2 diabetes and hypertension (HTN)

    Father is 76 years old – Osteoarthritis

    Sister is 54 years old – No history
    Maternal Grandma deceased at age 72 years – Diabetes, Neuropathy, HTN

    Maternal Grandfather deceased at age 78 years – Congestive heart failure (CHF)

    Paternal Grandmother is 80 years old and living – HTN

    Paternal Grandfather died at 64 years – Basal cell carcinoma, Seasonal allergies

    **Social History:**

    ·
    **Tobacco:** Denies tobacco, illicit drugs, and e-cigarette use.

    ·
    **Alcohol:** Drinks alcohol occasionally. The last drink was February 10th, 2025

    ·
    **Marital History:** Lives with husband

    ·
    **Occupation:** Social worker

    ·
    **Sleep/Stress:** Denies stress at home and work. Sleeps well

    ·
    **Exercise/Diet:** Eats a regular diet

    ·
    **Safety:** Uses seat belts in vehicles and does not own a gun.

    ·
    **Hobbies:** Swimming, reading

    ·
    **Spiritual affiliation:** Denies any affiliation

    **Sexual History:**

    · D. K. has one sexual partner

    · she
    is
    sexually active

    · She prefers males

    ·
    D. K.
    denies sexually transmitted diseases (STIs)

    · She does not use any form of protection

    · Patient has no plans for pregnancy.

    **Review of Systems (ROS)**

    ·
    **General:** D. K. reports 6lbs weight loss, weakness, and fatigue,
    denies fever and chills

    ·
    **Eyes:** Reports occasional blurred vision, denies pain, redness, and eye tearing,

    ·
    **Ears/ Nose/Throat/mouth:** Denies difficulty hearing, ringing in the ear, ear pain, or drainage. Denies sinus pain or epistaxis. Denies sore throat or hoarse voice. Denies bleeding gum and dry mouth. Reports last dental exam was on September 2024.

    ·
    **Cardiovascular:** Denies chest pain or palpitations.

    ·
    **Pulmonary**: Denies cough, hemoptysis, difficulty breathing, wheezing or chest tightness

    ·
    **Gastrointestinal:** Denies nausea and vomiting.

    ·
    **Genitourinary:** Denies difficulty passing Urine, blood in urine, urgency and frequency

    ·
    **Musculoskeletal:** Denies joint pain and stiffness

    ·
    **Endocrine:** Denies hot or cold intolerance, polyurea, polydipsia and polyphagia.

    ·
    **Integumentary:** Denies any rash, masses and wounds

    ·
    **Neurological:** Denies headache, dizziness, numbness and tingling

    ·
    **Lymphatic:** Denies feeling any swollen lymph nodes in the neck.

    ·
    **Allergy:** Denies seasonal or environmental allergies
    **,**

    ·
    **Hematologic/lymphatic:** Denies abnormal, anemia and easy bruising

    ·
    **Infectious diseases:** Denies history of infectious diseases

    ·
    **Cancer:** Denies history of colon or lung cancer

    ·
    **Psychiatric:** Denies
    depression,
    anxiety, and
    suicidal ideation

    **Objective**

    **Vital Sign**: Temperature: 97.9 F

    **Pulse:** 82

    **Respirations:** 18

    **BP:** 128/77

    **O2 sat:** 100% on room air

    **Pain Scale:** 0/10

    **Weight:** 210lb, Ht: 65in, BMI: 34.9

    **Physical Exam**

    **General Survey:** Patient is pleasant, well groomed, and in no acute distress

    **Laboratory results:** HbA1c 7.5%, fasting blood glucose 150mg/dL, Lipid level

    **HEENT:**

    **Head:** Atraumatic, symmetric scalp, hair has equal distribution and full thickness, no rashes

    **Eyes:** Sclera is white PERRLA, red reflex present, cup to disc ratio 1:3

    **Ear:** The ear canal is moist, the tympanic membrane is pearly grey and intact, no discharge

    **Nose:** Nasal mucosa is pink and moist, no discharge, no septum deviation

    **Mouth/Throat:** Mucous membrane is pink and moist, and tonsils are midline. No palpable mass or lymph node.

    **Skin:** Normal for ethnicity, smooth, warm, and dry. Good skin turgor, no lesions, rashes, ecchymosis, or moles. Nails are without clubbing or cyanosis.

    **Neurology:** Alert and oriented to person, place, and time. The patient is appropriate and answering questions well.

    **Cardiovascular:** Regular rate and rhythm. S1 S2, no clicks, heaves, thrills, or murmurs.

    **Pulmonary:** Chest is symmetric with bilateral expansion. Respirations are even and unlabored. Lung sounds are clear, with no accessory muscle use and no nasal flaring. Lung sounds are clear bilaterally in all fields.

    **Gastrointestinal:** Active bowel sounds in all quadrants, no palpable masses

    **Genitourinary:** No bladder distention noted

    **Psychiatric:** Behavior
    is age-appropriate, no anxiety or depression noted

    **Assessment**

    **Diagnosis**

    1.
    **Adult Type 2 Diabetes Mellitus (ICD-10: E11.9)**

    Diabetes results when the pancreas produces insulin that is not enough for the body's metabolism and when the body is not able to use available insulin. Diabetes is a chronic disease that leads to hypercalcemia, and uncontrolled diabetes causes problems to the body system, especially the nerves and blood vessels. Symptoms of diabetes include Polydipsia, which is excessive thirst, polyuria which is frequent urination, unintentional weight loss, feeling fatigued or tired, and blurred vision (WHO, 2024). These correlate with D. K’s symptoms at the time.

    **Differential Diagnosis**

    2.
    **Metabolic syndrome (ICD-10: E88.810)**

    Metabolic syndrome consists of metabolic abnormalities, including central obesity, insulin resistance, hypertension, and dyslipidemia, which are risk factors leading to atherosclerosis, cardiovascular disease, and type diabetes mellitus. Metabolic syndrome is diagnosed in the presence of three or more metabolic abnormalities. This diagnosis is ruled out due to the patient’s normal blood pressure (Swarup et al., 2024).

    3.
    **Drug-Induced Diabetes (ICD-10: E09.65)**

    Drug-induced diabetes mellitus occurs as a result of the use of a particular medication. It is a form of secondary diabetes that may be reversible when the use of the medication is discontinued, or diabetes may become permanent. The use of drugs such as corticosteroids, Betablockers, thiazide diuretics, antipsychotics, and statins can lead to drug-induced diabetes (Diabetes.co.uk, 2023). This condition is ruled out because D. K. is not on any of these medications.

    4.
    **Hyperthyroidism (ICD10: E03.9)**

    When the thyroid gland secretes excessive thyroid hormone, it is known as hyperthyroidism. Hyperthyroidism is more prevalent in women over 60 years of age. Risk factors include a family history of thyroid disease, pernicious anemia, and primary adrenal insufficiency. Symptoms are weight loss regardless of increased appetite, rapid or irregular heart rate, and irritability (NIH, 2025). Hyperthyroidism is ruled out due to the patient's age of less than 60 years, no complaints of irritability, and no family history of the disease.

    **Plan:**

    ·
    **Diagnostics:** Hemoglobin A1c (HbA1c) measures a person’s average blood glucose control over 90 days used to diagnose diabetes (Eyth & Naik, 2023).

    · A lipid panel is drawn to measure the patient’s cholesterol levels which should managed with statins if levels are high (ADA, 2023).

    · Thorough foot exam to assess for diabetic neuropathy, foot ulcers, and eye examination for diabetic retinopathy.

    **Patient results:** Hemoglobin AIC is 7.5%, Total cholesterol 210, BP 128/77

    **Treatment**

    · Patient is prescribed Metformin 500mg by mouth daily for elevated blood glucose.

    · 80mg of Atorvastatin by mouth daily for elevated cholesterol

    **Education**

    · Patient education is focused on home blood glucose self-monitoring according to ADA (2023).

    · Patient teaching about Hyperglycemia and hypoglycemia (ADA, 2023)

    · Emphasizing the importance of lifestyle modification, including eating a healthy diet low in carbohydrates and a regular aerobic exercise regimen of 150 minutes every week (ADA, 2023).

    · Importance of medication adherence (ADA, 2023).

    · Daily foot inspection (ADA, 2023)

    · Yearly eye exam (ADA, 2023)

    **Follow Up**

    Follow up with NP in two weeks to evaluate medication treatment with lifestyle changes. Medication adjustment will be required for blood glucose above the recommended level (ADA, 2023).

    References

    American Diabetes Association (ADA) (2023). Standards of medical care in diabetes

    2023.
    _Diabetes Care_,
    _46_(1), S1–S150.
    [https://doi.org/10.2337/dc23-S001](https://doi.org/10.2337/dc23-S001)

    Diabetes.co.uk. (2023). Drug induced diabetes.
    [https://www.diabetes.co.uk](https://www.diabetes.co.uk/)

    Swarup, s., Ahmed, I., Grigorova, Y., & Zeltser, R. (2024). Metabolic syndrome.

    In StatPearls. Treasure Island, (FL).
    [Https://www.ncbi.nlm.nih.gov/books/NBK](https://www.ncbi.nlm.nih.gov/books/NBK)

    World Health Organization (WHO). (2024). Diabetes.
    [Www.who.int/news-room/fac](http://www.who.int/news-room/fac)

    ·

    **## Gowalk94.docx**

    STI

    Due: Saturday, 4/26

    **Patient**

    B.G. is a 22-year-old Caucasian female presenting with a 1-week history of painful genital sores. She reports a burning sensation with urination and notes the presence of multiple small blisters on her vulva that ruptured into ulcers. She denies any prior episodes of similar symptoms. She also reports low-grade fever and general malaise. Associated symptoms: Dysuria, Itching, Tingling sensation before the appearance of sores, No vaginal discharge.

    **instructions**

    · Please complete STI SOAP Note precisely like the SOAP note you completed earlier for me in Asthma.

    · Must have a primary diagnosis and three differential diagnoses

    · Every idea is cited and referenced with literature within 5 years

    · Must have the Medication the patient is taking, Allergies. Social history, Sexual history, family history

    · Must have a review of systems

    · Physical examination

    · Diagnostic studies

    · Treatment

    · Patient education

    · Follow up

    · Must be in a basic Microsoft Word document

    · APA format.

    References reachable and within 5 years

    **Sample Note – Please follow this exact to complete**

    ID: D. K is a 70-year-old African American female, born on 06/10/1969, who presents to the clinic for a follow-up and laboratory review. The patient is accompanied by her husband, and she is a reliable source of information.

    **Subjective:**

    **CC:** “I feel tired all the time, and I have had increased thirst and urination in the past three months.”

    **HPI:**

    D.K. is a 70-year-old African American female who presents for follow-up for lab review and management of symptoms of polydipsia, polyuria, and fatigue and a possible diagnosis of type 2 diabetes mellitus. The patient reported experiencing increased thirst, increased hunger, urinary frequency, and fatigue in the past three months. D. K thought it was due to her consumption of cucumber, which she had just started consuming, but decided to seek help when she observed occasional blurred vision. She has also noted a 6-pound weight loss in these in these months. The patient’s fasting blood glucose level last visit was 150mg/dl, and HbA1c was 7.5%, which led to a diagnosis of type 2 diabetes mellitus. D.K. has a family history of diabetes, and she is currently not on any diabetes medication. She is following up for lab review and management. The last dental examination was on February 23rd, 2024. The last eye exam was on August 1st, 2023.

    **Past Medical History:** Denies any past medical history.

    **Hospitalization / Surgical**:

    Denies past or current
    surgeries/hospitalizations since the last visit

    **Allergies:**

    Denies drug allergies.

    Denies food allergies

    Denies seasonal allergies

    **Medications:**

    1. Melatonin for Insomnia for sleep

    2. Ibuprofen 200mg, 8 hours by mouth as needed for aches and pain

    3. Centrum Multivitamin 1 tablet by mouth daily

    4. Denies any prescription medication

    **Vaccinations:**

    · All childhood vaccines are current

    · Last flu shot 09/15/ 2024.

    · Covid Vaccines 01/14/2023, Covid Booster 03/15/2023

    **LMP:** The patient is post-menopausal

    **Family History:**

    The patient’s mother is 74 years old – with a history of type 2 diabetes and hypertension (HTN)

    Father is 76 years old – Osteoarthritis

    Sister is 54 years old – No history
    Maternal Grandma deceased at age 72 years – Diabetes, Neuropathy, HTN

    Maternal Grandfather deceased at age 78 years – Congestive heart failure (CHF)

    Paternal Grandmother is 80 years old and living – HTN

    Paternal Grandfather died at 64 years – Basal cell carcinoma, Seasonal allergies

    **Social History:**

    ·
    **Tobacco:** Denies tobacco, illicit drugs, and e-cigarette use.

    ·
    **Alcohol:** Drinks alcohol occasionally. The last drink was February 10th, 2025

    ·
    **Marital History:** Lives with husband

    ·
    **Occupation:** Social worker

    ·
    **Sleep/Stress:** Denies stress at home and work. Sleeps well

    ·
    **Exercise/Diet:** Eats a regular diet

    ·
    **Safety:** Uses seat belts in vehicles and does not own a gun.

    ·
    **Hobbies:** Swimming, reading

    ·
    **Spiritual affiliation:** Denies any affiliation

    **Sexual History:**

    · D. K. has one sexual partner

    · she
    is
    sexually active

    · She prefers males

    ·
    D. K.
    denies sexually transmitted diseases (STIs)

    · She does not use any form of protection

    · Patient has no plans for pregnancy.

    **Review of Systems (ROS)**

    ·
    **General:** D. K. reports 6lbs weight loss, weakness, and fatigue,
    denies fever and chills

    ·
    **Eyes:** Reports occasional blurred vision, denies pain, redness, and eye tearing,

    ·
    **Ears/ Nose/Throat/mouth:** Denies difficulty hearing, ringing in the ear, ear pain, or drainage. Denies sinus pain or epistaxis. Denies sore throat or hoarse voice. Denies bleeding gum and dry mouth. Reports last dental exam was on September 2024.

    ·
    **Cardiovascular:** Denies chest pain or palpitations.

    ·
    **Pulmonary**: Denies cough, hemoptysis, difficulty breathing, wheezing or chest tightness

    ·
    **Gastrointestinal:** Denies nausea and vomiting.

    ·
    **Genitourinary:** Denies difficulty passing Urine, blood in urine, urgency and frequency

    ·
    **Musculoskeletal:** Denies joint pain and stiffness

    ·
    **Endocrine:** Denies hot or cold intolerance, polyurea, polydipsia and polyphagia.

    ·
    **Integumentary:** Denies any rash, masses and wounds

    ·
    **Neurological:** Denies headache, dizziness, numbness and tingling

    ·
    **Lymphatic:** Denies feeling any swollen lymph nodes in the neck.

    ·
    **Allergy:** Denies seasonal or environmental allergies
    **,**

    ·
    **Hematologic/lymphatic:** Denies abnormal, anemia and easy bruising

    ·
    **Infectious diseases:** Denies history of infectious diseases

    ·
    **Cancer:** Denies history of colon or lung cancer

    ·
    **Psychiatric:** Denies
    depression,
    anxiety, and
    suicidal ideation

    **Objective**

    **Vital Sign**: Temperature: 97.9 F

    **Pulse:** 82

    **Respirations:** 18

    **BP:** 128/77

    **O2 sat:** 100% on room air

    **Pain Scale:** 0/10

    **Weight:** 210lb, Ht: 65in, BMI: 34.9

    **Physical Exam**

    **General Survey:** Patient is pleasant, well groomed, and in no acute distress

    **Laboratory results:** HbA1c 7.5%, fasting blood glucose 150mg/dL, Lipid level

    **HEENT:**

    **Head:** Atraumatic, symmetric scalp, hair has equal distribution and full thickness, no rashes

    **Eyes:** Sclera is white PERRLA, red reflex present, cup to disc ratio 1:3

    **Ear:** The ear canal is moist, the tympanic membrane is pearly grey and intact, no discharge

    **Nose:** Nasal mucosa is pink and moist, no discharge, no septum deviation

    **Mouth/Throat:** Mucous membrane is pink and moist, and tonsils are midline. No palpable mass or lymph node.

    **Skin:** Normal for ethnicity, smooth, warm, and dry. Good skin turgor, no lesions, rashes, ecchymosis, or moles. Nails are without clubbing or cyanosis.

    **Neurology:** Alert and oriented to person, place, and time. The patient is appropriate and answering questions well.

    **Cardiovascular:** Regular rate and rhythm. S1 S2, no clicks, heaves, thrills, or murmurs.

    **Pulmonary:** Chest is symmetric with bilateral expansion. Respirations are even and unlabored. Lung sounds are clear, with no accessory muscle use and no nasal flaring. Lung sounds are clear bilaterally in all fields.

    **Gastrointestinal:** Active bowel sounds in all quadrants, no palpable masses

    **Genitourinary:** No bladder distention noted

    **Psychiatric:** Behavior
    is age-appropriate, no anxiety or depression noted

    **Assessment**

    **Diagnosis**

    1.
    **Adult Type 2 Diabetes Mellitus (ICD-10: E11.9)**

    Diabetes results when the pancreas produces insulin that is not enough for the body's metabolism and when the body is not able to use available insulin. Diabetes is a chronic disease that leads to hypercalcemia, and uncontrolled diabetes causes problems to the body system, especially the nerves and blood vessels. Symptoms of diabetes include Polydipsia, which is excessive thirst, polyuria which is frequent urination, unintentional weight loss, feeling fatigued or tired, and blurred vision (WHO, 2024). These correlate with D. K’s symptoms at the time.

    **Differential Diagnosis**

    2.
    **Metabolic syndrome (ICD-10: E88.810)**

    Metabolic syndrome consists of metabolic abnormalities, including central obesity, insulin resistance, hypertension, and dyslipidemia, which are risk factors leading to atherosclerosis, cardiovascular disease, and type diabetes mellitus. Metabolic syndrome is diagnosed in the presence of three or more metabolic abnormalities. This diagnosis is ruled out due to the patient’s normal blood pressure (Swarup et al., 2024).

    3.
    **Drug-Induced Diabetes (ICD-10: E09.65)**

    Drug-induced diabetes mellitus occurs as a result of the use of a particular medication. It is a form of secondary diabetes that may be reversible when the use of the medication is discontinued, or diabetes may become permanent. The use of drugs such as corticosteroids, Betablockers, thiazide diuretics, antipsychotics, and statins can lead to drug-induced diabetes (Diabetes.co.uk, 2023). This condition is ruled out because D. K. is not on any of these medications.

    4.
    **Hyperthyroidism (ICD10: E03.9)**

    When the thyroid gland secretes excessive thyroid hormone, it is known as hyperthyroidism. Hyperthyroidism is more prevalent in women over 60 years of age. Risk factors include a family history of thyroid disease, pernicious anemia, and primary adrenal insufficiency. Symptoms are weight loss regardless of increased appetite, rapid or irregular heart rate, and irritability (NIH, 2025). Hyperthyroidism is ruled out due to the patient's age of less than 60 years, no complaints of irritability, and no family history of the disease.

    **Plan:**

    ·
    **Diagnostics:** Hemoglobin A1c (HbA1c) measures a person’s average blood glucose control over 90 days used to diagnose diabetes (Eyth & Naik, 2023).

    · A lipid panel is drawn to measure the patient’s cholesterol levels which should managed with statins if levels are high (ADA, 2023).

    · Thorough foot exam to assess for diabetic neuropathy, foot ulcers, and eye examination for diabetic retinopathy.

    **Patient results:** Hemoglobin AIC is 7.5%, Total cholesterol 210, BP 128/77

    **Treatment**

    · Patient is prescribed Metformin 500mg by mouth daily for elevated blood glucose.

    · 80mg of Atorvastatin by mouth daily for elevated cholesterol

    **Education**

    · Patient education is focused on home blood glucose self-monitoring according to ADA (2023).

    · Patient teaching about Hyperglycemia and hypoglycemia (ADA, 2023)

    · Emphasizing the importance of lifestyle modification, including eating a healthy diet low in carbohydrates and a regular aerobic exercise regimen of 150 minutes every week (ADA, 2023).

    · Importance of medication adherence (ADA, 2023).

    · Daily foot inspection (ADA, 2023)

    · Yearly eye exam (ADA, 2023)

    **Follow Up**

    Follow up with NP in two weeks to evaluate medication treatment with lifestyle changes. Medication adjustment will be required for blood glucose above the recommended level (ADA, 2023).

    References

    American Diabetes Association (ADA) (2023). Standards of medical care in diabetes

    2023.
    _Diabetes Care_,
    _46_(1), S1–S150.
    [https://doi.org/10.2337/dc23-S001](https://doi.org/10.2337/dc23-S001)

    Diabetes.co.uk. (2023). Drug induced diabetes.
    [https://www.diabetes.co.uk](https://www.diabetes.co.uk/)

    Swarup, s., Ahmed, I., Grigorova, Y., & Zeltser, R. (2024). Metabolic syndrome.

    In StatPearls. Treasure Island, (FL).
    [Https://www.ncbi.nlm.nih.gov/books/NBK](https://www.ncbi.nlm.nih.gov/books/NBK)

    World Health Organization (WHO). (2024). Diabetes.
    [Www.who.int/news-room/fac](http://www.who.int/news-room/fac)

    ·